Danish Biotech Stock News

Bavarian Nordic (CPSE:BAVA) has opened 2026 with Q1 revenue of DKK 1,057.8 million and Basic EPS of DKK 0.20, while the trailing twelve months show revenue of DKK 5.96 billion and Basic EPS of DKK 14.86. This sets a clear snapshot of the current run rate. Over recent quarters, revenue has moved from DKK 2,093.9 million in Q4 2024 to DKK 1,346.6 million in Q1 2025 and DKK 1,057.8 million in Q1 2026. Basic EPS shifted from DKK 10.15 to DKK 2.70 and then DKK 0.20. The latest release therefore...

A lackluster earnings announcement from Trifork Group AG ( CPH:TRIFOR ) last week didn't sink the stock price. Our...

H+H International A/S ( CPH:HH ) shareholders are probably feeling a little disappointed, since its shares fell 2.5% to...

Last week saw the newest half-year earnings release from Coloplast A/S ( CPH:COLO B ), an important milestone in the...

H. Lundbeck A/S ( CPH:HLUN B ) just released its latest quarterly results and things are looking bullish. H. Lundbeck...

The most recent earnings report from Genmab A/S ( CPH:GMAB ) was disappointing for shareholders. While the headline...

RTX (CPSE:RTX) has just posted Q2 2026 results with revenue of 164.3 million DKK and Basic EPS of 1.3 DKK, against a backdrop of trailing 12 month revenue of 581.7 million DKK and EPS of 1.45 DKK that marks a clear contrast with the loss reported in Q1 2026. Over recent quarters the company has seen revenue move from 165.5 million DKK in Q2 2025 to 146.7 million DKK in Q4 2025, then to 115.9 million DKK in Q1 2026 and now 164.3 million DKK. EPS shifted from 0.99 DKK to 0.57 DKK, then a loss...

Q1 results and reaffirmed margin outlook put Pandora in focus Pandora (CPSE:PNDORA) is in the spotlight after reporting Q1 2026 earnings showing sales of DKK 7,109 million and net income of DKK 942 million, while reiterating full year EBIT margin guidance of 21% to 22%. See our latest analysis for Pandora. The reaffirmed EBIT margin guidance comes as Pandora's share price trades at DKK 516.2, with a 1 day share price return of 1.02% but a year to date share price decline of 25.79%. The 1 year...

A.P. Møller & Mærsk (CPSE:MAERSK B) is rerouting vessels away from the Strait of Hormuz in response to escalating Middle East tensions. The company is restructuring trade routes to keep cargo moving while limiting exposure to a key geopolitical flashpoint. This shift is part of a broader move toward more flexible, resilient global supply chains. For a stock like CPSE:MAERSK B, where investors track both freight trends and geopolitical risk, this operational shift is highly relevant. The...

NKT (CPSE:NKT) has opened 2026 with Q1 revenue of €864 million and basic EPS of €1.08, alongside trailing 12 month revenue of €3.6 billion and EPS of €5.00 that frame the latest quarterly print in a wider earnings context. Over recent periods, the company has reported quarterly revenue between €837 million and €945 million, with basic EPS ranging from €0.95 to €1.77, while trailing 12 month EPS has been in a range of €4.19 to €5.00 as revenue moved from €3.3 billion to €3.6 billion. This...

Københavns Lufthavne (CPSE:KBHL) has opened 2026 with Q1 revenue of DKK 1.2 billion and basic EPS of DKK 19.00, set against trailing 12 month EPS of DKK 162.52. Over the past year, the company has seen revenue move from DKK 5.07 billion to DKK 5.65 billion and EPS climb from DKK 129.46 to DKK 162.52, alongside earnings growth of 26.2%. This leaves you looking at a business where higher net profit margins and solid profitability are central to the current earnings story. See our full analysis...

FLSmidth (CPSE:FLS) opened 2026 with Q1 revenue of DKK 3.3b and basic EPS of DKK 18.1, set against a trailing twelve month revenue base of DKK 14.2b and EPS of DKK 24.16 that reflects a 23.3% rise in earnings over the past year. Over recent quarters the company has seen revenue move from DKK 3.7b in Q1 2025 to DKK 3.3b in Q1 2026, while quarterly basic EPS has shifted from DKK 5.44 to DKK 18.1, with that earnings trajectory feeding into higher net profit margins. Overall, these results point...

TORM, ticker CPSE:TRMD A, reported a strong Q1 2026 earnings surge. Geopolitical tensions and the closure of the Strait of Hormuz pushed freight rates to record highs. The company upgraded full year guidance and moved ahead with a fleet renewal plan, adding new vessels. TORM focuses on product tankers that transport refined oil products, so freight disruptions and route changes directly affect its earnings power. With key shipping lanes constrained and rerouted, demand for available,...

As European markets navigate a period of modest gains amidst easing geopolitical tensions and strong corporate earnings, the pan-European STOXX Europe 600 Index reflects a cautiously optimistic sentiment. With potential interest rate hikes on the horizon from the European Central Bank and rising producer price inflation, investors are increasingly attentive to identifying stocks that exhibit resilience and growth potential in this dynamic environment. Exploring undiscovered gems within...

Gubra A/S ( CPH:GUBRA ) shareholders will have a reason to smile today, with the analysts making substantial upgrades...

Investors were disappointed with the weak earnings posted by Netcompany Group A/S ( CPH:NETC ). While the headline...

Unsurprisingly, Zealand Pharma A/S' ( CPH:ZEAL ) stock price was strong on the back of its healthy earnings report. We...

Dampskibsselskabet Norden A/S ( CPH:DNORD ) recently posted soft earnings but shareholders didn't react strongly. We...

Novo Nordisk (CPSE:NOVO B) has transferred its clinical-stage Parkinson’s cell therapy program to AI-focused Cellular Intelligence. The move marks an exit from direct cell therapy development while keeping exposure to AI driven biotech through the partnership. The Parkinson’s therapy involved holds an FDA fast-track designation, placing it among higher-priority programs for potential patients. For investors tracking CPSE:NOVO B, this shift comes as the stock trades around DKK300.55, with a...

H+H International (CPSE:HH) opened 2026 with Q1 revenue of DKK 560 million and a reported loss per share of DKK 2.8, while on a trailing 12 month basis EPS stood at a loss of DKK 42.90 on revenue of DKK 2.63 billion. The company has seen quarterly revenue move from DKK 675 million and a loss per share of DKK 0.7 in Q1 2025 to DKK 560 million and a loss per share of DKK 2.8 in Q1 2026. Trailing 12 month net income shifted from a loss of DKK 662 million in Q4 2025 to a loss of DKK 697 million...

Q1 2026 earnings set the stage for North Media North Media (CPSE:NORTHM) has kicked off 2026 with Q1 revenue of DKK293.7 million and a basic EPS loss of DKK1.7, while trailing 12 month EPS stands at DKK8.17 on revenue of DKK1,279.2 million and net income of DKK148.2 million. Over the past year, revenue across reported periods has ranged between DKK286.4 million and DKK356.8 million per quarter, with basic EPS swinging from a loss of DKK10.12 to a gain of DKK5.29. That gives investors a wide...

H. Lundbeck (CPSE:HLUN B) has kicked off the Q1 2026 reporting season with recent quarterly figures that show Q4 2025 revenue of DKK6.1 billion and a basic EPS loss of DKK0.03, while trailing 12 month EPS sat at DKK3.22 on revenue of DKK24.6 billion. Over recent quarters, revenue has ranged from DKK5.5 billion in Q4 2024 to between DKK6.0 billion and DKK6.3 billion across the 2025 quarters. Quarterly EPS moved from DKK0.60 to DKK1.16 before the latest loss, setting up a mixed backdrop as you...

As the pan-European STOXX Europe 600 Index concluded a turbulent week with modest gains, investor sentiment was buoyed by easing geopolitical tensions and robust corporate earnings across the region. However, concerns over potential U.S. tariffs on EU goods introduced some volatility into the markets. In this environment, identifying stocks that may be priced below their intrinsic value estimates can offer opportunities for investors seeking to capitalize on market inefficiencies and strong...

Coloplast (CPSE:COLO B) Q2 2026 earnings in focus Coloplast (CPSE:COLO B) has kicked off its Q2 2026 reporting with Q1 figures that put hard numbers around the story, with revenue at about DKK7.0 billion, basic EPS of DKK6.21 and net income of DKK1.40 billion. These results are backed by trailing 12 month totals of DKK27.9 billion in revenue, DKK17.70 in EPS and DKK4.0 billion in net income. Over recent quarters the company has seen revenue hover in a tight band between DKK6.93 billion and...